Skip to content
Open access

TMEDRP: decoding tumor-intrinsic and microenvironmental signatures for clinical drug response prediction

Sep 2026 · Bioinformatics · Vol 42 · 0 citations · 36 references
Medicine

TL;DR

TMEDRP is a novel two-stage learning framework that integrates tumor-intrinsic signatures and TME-specific components for enhanced clinical drug response prediction and exhibits promising zero-shot generalization across unseen cancer lineages and novel compounds, suggesting its robustness across diverse scenarios.

Abstract

Abstract Motivation Clinical drug response prediction is constrained by the paucity of patient data, forcing a reliance on in vitro cell line models. Current transfer learning-based methods typically focus on learning domain-invariant representations, but often overlook the critical role of tumor microenvironment (TME) during cross-domain translation. Given that TME discrepancies between in vitro and in vivo settings are critical factors of therapeutic resistance, explicitly modeling the TME is essential to bridge the gap between preclinical models and patient-specific responses. Results We propose TMEDRP, a novel two-stage learning framework that integrates tumor-intrinsic signatures and TME-specific components for enhanced clinical drug response prediction. TMEDRP introduces TME influences via a pathway-informed disentanglement strategy, a neural co-expression module, and an uncertainty-driven adaptation mechanism. Extensive benchmarks demonstrate that TMEDRP outperforms existing state-of-the-art methods. Importantly, it exhibits promising zero-shot generalization across unseen cancer lineages and novel compounds, suggesting its robustness across diverse scenarios. Furthermore, quantitative analysis of the model’s latent embeddings uncovers key tumor-intrinsic pathways and extrinsic TME factors that distinguish drug-sensitive from resistant cohorts. The identified shared and drug-specific molecular markers align with established clinical mechanisms, supporting the model’s biological interpretability and clinical utility. Availability and implementation The code and results are available at https://github.com/kybinn/TMEDRP.

Read PDF

Similar papers

Sep 2026

UniCure: A multi-modal model for predicting personalized cancer therapy response.

UniCure is presented, a multi-modal model that combines biological and chemical foundation models to predict drug-induced transcriptomic responses across diverse cell and tissue contexts, enabling individualized drug ranking.

Ze-Xi Chen, Saisai Tian, Jia-Zheng Pei et al. · 0 citations
Open access Sep 2026

AI‑Driven Multi‑Omics Integrative Model for Predicting Tumor‑Specific Drug Responses

An AI-driven multi-omics model using GDSC, CCLE, DepMap, CTRP, and TCGA data, integrating mutation, copy-number variation, RNA expression, DNA methylation, drug SMILES, and IC50/AUC responses is developed, demonstrating that multi-omics fusion and drug-structure modeling improve prediction stability and support interpr...

Xin-Yuan Kang, Ai-Lin Deng · 0 citations
Open access Aug 2026

NELLY enables patient-centric drug prioritization through interpretable drug-conditioned gene weighting

A translational framework combining patient-centric benchmarking with a pan-cancer pharmacogenomic atlas of patient-derived organoids and a deep learning model integrating transcriptomic and chemical information to predict drug response and prioritize therapies is introduced, supporting NELLY as a promising framework f...

C. Peralta Viteri, N. Harnischfeger, Lili Szabo et al. · 0 citations
Open access Sep 2026

AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning

AET5 is presented, a de novo molecular generation framework that conditions molecular design on disease-reversal gene expression profiles, providing a general framework for biologically informed drug design under noisy transcriptomic conditions.

Zhi-Kang Yuan, Xin Zhang, Gao-Ming Lin et al. · 0 citations
Open access Aug 2026

Causally-inspired meta-representation learning framework for predicting patient-specific clinical responses to drug combinations

CaMeRe, a Causally-inspired Meta-representation learning framework designed to predict patient-specific clinical Response to drug combinations, exhibited robust multi-domain generalization performance across multiple clinical drug combination response datasets and PDXs drug combination response datasets and generalizat...

Qing-Qing Zhang, Shao-Wu Zhang, Ming-Hui Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.